Brain-specific control of kynurenic acid production by depolarizing agents.
Gramsbergen
J B
JB
Maryland Psychiatric Research Center, Baltimore 21228.
Turski
W A
WA
Schwarcz
R
R
D000818:Animals; D001253:Astrocytes / Q000187:drug effects / Q000378:metabolism; D001923:Brain Chemistry / Q000187:drug effects*; D002118:Calcium / Q000494:pharmacology; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism; D007736:Kynurenic Acid / Q000378:metabolism*; D008099:Liver / Q000378:metabolism; D008274:Magnesium / Q000494:pharmacology; D008297:Male; D009474:Neurons / Q000187:drug effects; D009928:Organ Specificity; D011188:Potassium / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D015222:Sodium Channels / Q000187:drug effects / Q000378:metabolism; D013779:Tetrodotoxin / Q000494:pharmacology; D014701:Veratridine / Q000037:antagonists & inhibitors / Q000494:pharmacology*
D015222:Sodium Channels; D013779:Tetrodotoxin; D014701:Veratridine; D007736:Kynurenic Acid; D008274:Magnesium; D011188:Potassium; D002118:Calcium